Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis (Q35131199)

6 August 2017

title

Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis (English)

1 reference

6 August 2017

1 reference

Ivan Nestorov

1

1 reference

6 August 2017

Ralph Zitnik

2

1 reference

6 August 2017

Todd DeVries

3

1 reference

6 August 2017

Arline M Nakanishi

4

1 reference

6 August 2017

Andrea Wang

5

1 reference

6 August 2017

Christopher Banfield

6

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

British Journal of Clinical Pharmacology

6 August 2017

published in

1 reference

6 August 2017

volume

62

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

435-445

1 reference

Population-based pharmacokinetics of the soluble TNFr etanercept: a clinical study in 43 patients with ankylosing spondylitis compared with post hoc data from patients with rheumatoid arthritis

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636685

13 July 2018

Cytokines in psoriasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636685

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636685

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1636685

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment

13 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02581.X

A randomized trial of etanercept as monotherapy for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02581.X

Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02581.X

Absence of a clinically relevant interaction between etanercept and digoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02581.X

Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02581.X

The pharmacokinetics of etanercept in healthy volunteers

21 January 2018

1 reference

12 December 2020

Population pharmacokinetic modeling of subcutaneously administered etanercept in patients with psoriasis

1 reference

12 December 2020

New treatments for psoriasis

1 reference

12 December 2020

Etanercept as monotherapy in patients with psoriasis

1 reference

12 December 2020

Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression

1 reference

12 December 2020

A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction

1 reference

12 December 2020

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

12 December 2020

10.1111/J.1365-2125.2006.02581.X

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference